Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cynata Therapeutics Limited

Clinical trials sponsored by Cynata Therapeutics Limited, explained in plain language.

Cynata Therapeutics Limited CYP ASX

An Australian stem cell therapeutics company developing treatments for various diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New cell therapy aims to tame deadly transplant complication

Disease control Ongoing

This study tests a new treatment called CYP-001 for people who develop a severe immune reaction (graft versus host disease) after a stem cell transplant. About 60 participants will receive either CYP-001 plus standard steroids or a placebo plus steroids. The goal is to see if add…

Phase: PHASE2 • Sponsor: Cynata Therapeutics Limited • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC